Medication profile definition

Medication profile or "profile" means a record system maintained as to drugs or devices prescribed for a pharmacy patient to enable a pharmacist or pharmacy intern to analyze the profile to provide pharmaceutical care.
Medication profile or "profile" means a record system maintained as to drugs or
Medication profile or "profile" means a record system maintained as to

Examples of Medication profile in a sentence

  • The Patient Daily Medication Record provides a daily refill-by-refill audit trail on all drugs dispensed and supplements the base document, the Patient Medication profile.

  • If none, this should be indicated.(d) Medication profile records shall be maintained for a minimum period of 5 years following the date of the last dispensing.

  • Medication profile records shall be maintained for a period of not less than 5 years following the date of the last entry.

  • Medication profile update and screening for changes in health status, and tolerability of product (54, 35)IG 2.02.

  • Medication profile was reviewed with member at time of transition of care.

  • Medication profile was reviewed with outpatient provider at time of transition of care.

  • Forms shall include but not be limited to: a.) Medication and treatment administration record;b.) Non-formulary request form;c.) Physician order form or profile form, if applicable; d.) Medication profile (patient profile record);e.) Declining inventory form (for control of medications);f.) Back up supply utilization form (perpetual inventory control); g.) Stock medication formh.) Controlled medication Delivery Sheet.

  • If none, this should be indicated.(d) Medication profile records shall be maintained for a mini- mum period of 5 years following the date of the last dispensing.

  • In particular, the national collective agreement executed in November 2016, through its section IV, title III, article 5, encourages the workers’ and employers’ organizations to find, at company level, solutions to promote the conciliation between working time and private life.

  • Medication profile should be reviewed for other QT- prolonging agents (e.g. azithromycin, levofloxacin, sotalol, amiodarone, etc.).• When used with any other known QTc prolonging agents, these agents can have additive QTc-prolonging effects and therefore, increased associated risk of arrhythmic death.


More Definitions of Medication profile

Medication profile means a record and drug listing for each patient based on available information, containing but not limited to, patient name, patient age, sex, patient weight, current diagnosis, allergies or sensitivities, and current therapy.
Medication profile or "profile" means a record system maintained as to drugs or devices prescribed for a pharmacy patient to enable a pharmacist, or pharmacy intern to analyze for
Medication profile means the medication profile of the patient as stored in the PIP
Medication profile or "profile" means a record system maintained as to drugs or devices prescribed for a pharmacy patient to enable a pharmacist, or pharmacy intern to analyze for potential harmful or dangerous interactions, or other factors, or other drugs or devices prescribed for

Related to Medication profile

  • Disinfection profile means a summary of Giardia lamblia inactivation through the treatment plant.

  • DNA profile means a letter or number code which represents a set of identification characteristics of the non-coding part of an analysed human DNA sample, i.e. the particular molecular structure at the various DNA locations (loci);

  • DRS/Profile means the system for the uncertificated registration of ownership of securities pursuant to which ownership of ADSs is maintained on the books of the Depositary without the issuance of a physical certificate and transfer instructions may be given to allow for the automated transfer of ownership between the books of DTC and the Depositary. Ownership of ADSs held in DRS/Profile is evidenced by periodic statements issued by the Depositary to the Holders entitled thereto.

  • Dose profile means the dose as a function of position along a line.

  • Medication means any drug, chemical, compound, suspension, or preparation in suitable form for use as a curative or remedial substance taken either internally or externally by any person.

  • Medication error means any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems including, but not limited to: prescribing; order communication; product labeling, packaging and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Profile means a building's cross-sectional shape or the shape of its outline.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Routine patient care costs means Covered Medical Expenses which are typically provided absent a clinical trial and not otherwise excluded under the Policy. Routine patient care costs do not include:

  • Direction-indicator lamp means the lamp used to indicate to other road-users that the driver intends to change direction to the right or to the left;

  • Filter profile means a graphical representation of individual filter performance, based on continuous turbidity measurements or total particle counts versus time for an entire filter run, from startup to backwash inclusively, that includes an assessment of filter performance while another filter is being backwashed.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Prescription monitoring program means the electronic system within the Department of Health Professions that monitors the dispensing of certain controlled substances.

  • Monitoring Indicator means a measure of HSP performance that may be monitored against provincial results or provincial targets, but for which no Performance Target is set;

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Drug means (i) articles or substances recognized in the official United States Pharmacopoeia

  • MSAA Indicator Technical Specifications document means, as the context requires, either or both of the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Indicator Technical Specifications November 5, 2018 Version 1.3” and the document entitled “Multi-Sector Service Accountability Agreement (MSAA) 2019-20 Target and Corridor-Setting Guidelines” as they may be amended or replaced from time to time;

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Prescription medication means any medication that requires a physician prescription before it may be obtained from a pharmacist.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.